6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10096L | Voruciclib | CDK | |
Voruciclib is an orally active and selective CDK inhibitor (Ki: 0.626 nM-9.1 nM). Voruciclib represses the expression of MCL-1 in multiple models of diffuse large B-cell lymphoma. Voruciclib effectively blocks CDK9, the ... | |||
T13309 | Voruciclib hydrochloride | CDK | |
Voruciclib hydrochloride is an orally active and selective inhibitor of CDK (Ki: 0.626 nM-9.1 nM). | |||
T10096L2 | (2S,3R)-Voruciclib hydrochloride | (2S,3R)-Voruciclib hydrochloride (1253731-24-6 free base) | Others |
(2S,3R)-Voruciclib hydrochloride is the (2S,3R)-enantiomer of Voruciclib. It is an orally active CDK inhibitor. | |||
T10096 | (2S,3R)-Voruciclib | CDK | |
(2S,3R)-Voruciclib is the (2S,3R)-enantiomer of Voruciclib. It is an orally active CDK inhibitor. | |||
T63465 | (2S,3R)-Voruciclib hydrochloride | ||
(2S,3R)-Voruciclib hydrochloride is an isomer of Voruciclib hydrochloride. Voruciclib is an orally active CDK inhibitor. | |||
T78048 | Rel-(2S,3R)-Voruciclib hydrochloride | CDK | |
Rel-(2S,3R)-Voruciclib hydrochloride is an enantiomer of Voruciclib hydrochloride, an orally active cyclin-dependent kinase (CDK) inhibitor. |